Business Wire

Dow Launches DOWSIL™ EG-4175 Silicone Gel to Enable Higher Voltage Power Electronics in Electric Vehicles and Renewable Energy Technologies

4.9.2025 12:00:00 EEST | Business Wire | Press release

Share

Dow (NYSE: Dow) launched today DOWSIL™ EG-4175 Silicone Gel, a highly reliable protective solution for next-generation insulated gate bipolar transistor (IGBT) modules that operate at higher voltages. This new advanced material resists the higher temperatures associated with these IGBTs and supports greater reliability, lower power losses and higher power efficiencies in electric vehicle (EV) batteries and inverters for photovoltaic (PV) panels and wind turbines.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904309932/en/

DOWSIL™ EG-4175 Silicone Gel is a protective solution, for next-generation insulated gate bipolar transistor (IGBT) modules, that withstands temperatures up to 180°C. This innovative gel from Dow supports greater reliability, lower power losses and higher power efficiencies in high-voltage power electronics for electric vehicles and renewable energy applications.

Dow’s new DOWSIL™ EG-4175 Silicone Gel withstands temperatures up to 180°C and expands Dow’s growing portfolio of solutions for power electronics. The material also absorbs vibrations and has self-healing properties that repair small cracks without external intervention. It features self-priming adhesion for enhanced module protection and cures at room temperatures for excellent energy efficiency. Heat-accelerated curing may also be used to reduce cycle times.

“Dow is upgrading our IGBT materials portfolio to address the emerging trend toward achieving higher power densities,” said Cathy Chu, global strategic marketing director, Consumer & Electronics, Dow. “With its higher-temperature resistance compared to incumbent materials, this new silicone gel will enable our customers to design and manufacture higher-density IGBT modules with greater power system efficiency. This demonstrates Dow’s commitment to advancing the EV and renewable energy sectors, both of which contribute significantly to global carbon reduction.”

The launch of DOWSIL™ EG-4175 Silicone Gel supports key trends in EVs and renewable energy. In EVs, battery voltages are increasing from 400V to 800V to enable more efficient main inverter and faster battery charging. In PV panels and wind turbines, the power densities of inverters are increasing. This improves power efficiency and supports the handling of greater electrical loads. With higher junction temperature associated with higher voltages and greater electrical loads of the 7th generation IGBT technology, a silicone gel needs to have strong dielectric properties and enhanced thermal resistance.

Dow’s portfolio of silicone-based dielectric gel products provides thermal resistance, electrical insulation, encapsulation, stress relief, and mechanical and environmental protection. The company’s advanced DOWSIL™ EG-4175 Silicone Gel builds on these properties to provide several other advantages, including high-temperature resistance, low levels of silicone oil bleed and adhesion without a primer. Gels are a special class of encapsulant that can cure to an extremely soft material while providing the dimensional stability of an elastomer.

DOWSIL™ EG-4175 Silicone Gel joins DOWSIL™ EA-7158 Adhesive, an existing product, as part of Dow’s total solution for IGBT modules. DOWSIL™ EA-7158 Adhesive is a one-part, high-strength silicone product that provides excellent primerless adhesion to many substrates. This solvent-free, non-flowing material cures rapidly with heat and is translucent in color.

Both DOWSIL™ EG-4175 Silicone Gel and DOWSIL™ EA-7158 Adhesive are available globally.

About Dow

Dow (NYSE: DOW) is one of the world’s leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, focused innovation, leading business positions and commitment to sustainability enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 30 countries and employ approximately 36,000 people. Dow delivered sales of approximately $43 billion in 2024. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us and our ambition to be the most innovative, customer-centric, inclusive and sustainable materials science company in the world by visiting www.dow.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250904309932/en/

Contacts

For further information, please contact:

Eileen Zeng, Dow
+86 21 3851 1604
eyzeng@dow.com

Amanda Berrian, AH&M Inc.
+1 413-329-6887
aberrian@ahminc.com - asteinberg@ahminc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release

Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone

OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur

Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 16:30:00 EEST | Press release

Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country. The funding will advance Project Obsidian, the world's first commercial superhot geothermal power plant, in Central Oregon. It will support analysis of the drilling, stimulation, and flow results of the first two wells to optimize a third well at the Obsidian site. The three-well configuration is targeting average reservoir temperatures of over 300°C and is designed to demonstrate more than 25 megawatts of gross electric power capacity. The DOE funding will also enable Qu

From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 16:00:00 EEST | Press release

Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and their families access care, adopt healthier habits, and improve long-term oral health outcomes. “At Colgate-Palmolive, we believe oral health and healthier, brighter futures are inextricably link

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye